MSH3 and cancer: Thirteen of them were variants predicted as pathogenic by in silico tools, identified in well-known CRC predisposing genes such as APC and MUTYH, as well as variants in newly emerging cancer predisposing genes such as MSH3 and FAN1 (Table 4 and  Table S6).